Cardiovascular Disease, Cholesterol and Lipid disorders

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Cardiovascular Disease

Cholesterol

Lipid disorders

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report

Cardiometabolic Health Congress

AUGUST 23, 2024

Newly included risk factors— untreated vision loss and high LDL cholesterol —underscore the critical role of these elements in maintaining cognitive health. The Cholesterol Connection Cholesterol’s recognition as a risk factor for dementia marks a pivotal advancement in understanding, preventing, and delaying cognitive decline.

Dementia

Dementia Cholesterol Risk Factors CME

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

MARCH 8, 2024

1 The most common adverse event leading to discontinuation was gastrointestinal disorders, occurring in 10% of patients in the Wegovy group and 2% in the placebo group. Between 1999 and 2020, obesity-related cardiovascular disease deaths tripled in the U.S., in patients randomized to Wegovy 2.4 mg and 36.4% 10,11 In the U.S.,

Obesity

Obesity Heart Disease Heart Attack Heart attacks

Cardiovascular Update

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

Stay Connected